# Isolated signals in BCL2, MYC, BCL6, and DDIT3 FISH: implications for genetic alterations and protein dysregulation

**Authors:** Zongchen Wei, Qiuyue Chen, Zhenbo Feng, Fang Tang

PMC · DOI: 10.3389/pore.2026.1612284 · Pathology and Oncology Research · 2026-02-11

## TL;DR

This study explains how isolated FISH signals in certain genes can result from genetic changes and lead to protein overexpression in tumors.

## Contribution

The study identifies genetic mechanisms behind isolated FISH signals and links them to protein dysregulation in tumors.

## Key findings

- Isolated FISH signals in BCL2, MYC, BCL6, and DDIT3 were linked to gene translocations and deletions/inversions.
- Protein overexpression was observed in samples with isolated BCL2, MYC, and BCL6 signals.
- Genetic alterations in probe-binding regions disrupt FISH signal detection and affect clinical interpretation.

## Abstract

Fluorescence in situ hybridization (FISH) break-apart probes are widely employed to detect gene rearrangements in malignant tumors. Notwithstanding their utility, the complex genetic alterations in tumors frequently give rise to isolated signals, the mechanisms underlying which remain poorly understood. This study aimed to elucidate the genetic causes of isolated FISH signals in lymphoma and myxoid liposarcoma samples, providing a more accurate basis for interpreting FISH results.

Six cases of lymphoma and myxoid liposarcoma, which showed isolated signals for BCL2, MYC, BCL6, or DDIT3 in FISH detection, were carefully screened. Whole genome resequencing (WGR) was employed to analyze the genetic variations present in these samples. In addition, immunohistochemistry was used to assess the expression levels of the corresponding proteins in these samples.

WGR results revealed that all six cases with isolated signals harbored target gene translocations, with 5′and 3′probe-binding region deletions or inversions detected in BCL2, MYC, and BCL6, and in the 5′probe-binding region of DDIT3. Additionally, overexpression of the corresponding proteins was present in samples with isolated BCL2, MYC, and BCL6 signals.

Deletions or inversions in the probe-binding sequence regions may disrupt probe recognition and binding, leading to isolated FISH signals for BCL2, MYC, BCL6, and DDIT3. Notably, in cases with isolated BCL2, MYC, or BCL6 signals, translocations involving these genes were associated with increased expression of their encoded proteins. These findings improve the understanding of FISH signal interpretation in tumor gene rearrangement detection and provide a valuable reference for clinical diagnosis.

## Linked entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], BCL6 (BCL6 transcription repressor) [NCBI Gene 604], DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649]
- **Diseases:** lymphoma (MONDO:0003659), myxoid liposarcoma (MONDO:0013280)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, MAP2K1 (mitogen-activated protein kinase kinase 1) [NCBI Gene 5604] {aka CFC3, MAPKK1, MEK1, MEL, MKK1, PRKMK1}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, SMARCB1 (SWI/SNF related BAF chromatin remodeling complex subunit B1) [NCBI Gene 6598] {aka BAF47, CSS3, INI-1, INI1, MRD15, PPP1R144}, Bcl6 (B cell leukemia/lymphoma 6) [NCBI Gene 12053] {aka Bcl5}, TFE3 (transcription factor binding to IGHM enhancer 3) [NCBI Gene 7030] {aka MRXSPF, RCCP2, RCCX1, TFEA, bHLHe33}, CBFB (core-binding factor subunit beta) [NCBI Gene 865] {aka CLCD2, PEBP2B}, SS18 (SS18 subunit of BAF chromatin remodeling complex) [NCBI Gene 6760] {aka SMARCL1, SSXT, SYT}, FUS (FUS RNA binding protein) [NCBI Gene 2521] {aka ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS}, ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098] {aka MCF3, ROS, c-ros-1}, KMT2A (lysine methyltransferase 2A) [NCBI Gene 4297] {aka ALL-1, ALL1, CXXC7, GAS7, HRX, HTRX}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, BCL6 (BCL6 transcription repressor) [NCBI Gene 604] {aka BCL5, BCL6A, LAZ3, ZBTB27, ZNF51}, USP6 (ubiquitin specific peptidase 6) [NCBI Gene 9098] {aka HRP1, TRE17, TRE2, TRESMCR, Tre-2, USP6-short}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, Ddit3 (DNA-damage inducible transcript 3) [NCBI Gene 13198] {aka AltDDIT3, CHOP-10, CHOP10, chop, gadd153}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, ELK2AP (ETS transcription factor ELK2A, pseudogene) [NCBI Gene 2003] {aka ELK2, ELK2.1, ELK2P1}, EWSR1 (EWS RNA binding protein 1) [NCBI Gene 2130] {aka EWS, EWS-FLI1}, JAZF1 (JAZF zinc finger 1) [NCBI Gene 221895] {aka TIP27, ZNF802}, SSX2B (SSX family member 2B) [NCBI Gene 727837] {aka CT5.2, CT5.2b, HOM-MEL-40, SSX}, MIR4507 (microRNA 4507) [NCBI Gene 100616135], Myc (Myc proto-oncogene, bHLH transcription factor) [NCBI Gene 17869] {aka Myc2, Niard, Nird, bHLHe39}
- **Diseases:** malignancies (MESH:D009369), BL (MESH:D002051), acute myeloid leukemia (MESH:D015470), non-small cell lung cancer (MESH:D002289), FL (MESH:D008224), synovial sarcoma (MESH:D013584), MLPS (MESH:D018208), lymphoma (MESH:D008223), endometrial stromal sarcoma (MESH:D018203), teratoid rhabdoid tumor (MESH:C000597569), DLBCL (MESH:D016403)
- **Chemicals:** paraffin (MESH:D010232), formalin (MESH:D005557), DAPI (MESH:C007293)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** chr3:186,826,665-186,826,969, chr3:186,581,033-186,585,284

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932253/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932253/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932253/full.md

---
Source: https://tomesphere.com/paper/PMC12932253